Galectin-3 inhibitors as novel antithrombotic drugs with almost no bleeding risk: wishful thinking or a realistic vision?
Authors: Kai Jakobs, Ursula Rauch
Published: 2022-03-01
DOI:
10.1093/eurheartj/ehac128
Source:
Full article
Abstract
No abstract found.